nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—Lenalidomide—hematologic cancer	0.146	0.35	CbGbCtD
Clodronate—PTGS2—Thalidomide—hematologic cancer	0.0782	0.187	CbGbCtD
Clodronate—PTGS2—Triamcinolone—hematologic cancer	0.0542	0.129	CbGbCtD
Clodronate—PTGS2—Betamethasone—hematologic cancer	0.0465	0.111	CbGbCtD
Clodronate—PTGS2—Cisplatin—hematologic cancer	0.0335	0.08	CbGbCtD
Clodronate—PTGS2—Etoposide—hematologic cancer	0.0329	0.0786	CbGbCtD
Clodronate—PTGS2—Dexamethasone—hematologic cancer	0.027	0.0646	CbGbCtD
Clodronate—PTGS2—ovarian follicle—hematologic cancer	0.011	0.11	CbGeAlD
Clodronate—SLC25A6—hematopoietic system—hematologic cancer	0.00811	0.081	CbGeAlD
Clodronate—SLC25A5—hematopoietic system—hematologic cancer	0.00706	0.0705	CbGeAlD
Clodronate—SLC25A6—gonad—hematologic cancer	0.00617	0.0616	CbGeAlD
Clodronate—SLC25A6—blood—hematologic cancer	0.00537	0.0537	CbGeAlD
Clodronate—SLC25A5—gonad—hematologic cancer	0.00537	0.0536	CbGeAlD
Clodronate—SLC25A6—bone marrow—hematologic cancer	0.0052	0.0519	CbGeAlD
Clodronate—SLC25A4—gonad—hematologic cancer	0.00503	0.0502	CbGeAlD
Clodronate—SLC25A6—lung—hematologic cancer	0.00471	0.0471	CbGeAlD
Clodronate—SLC25A5—blood—hematologic cancer	0.00468	0.0467	CbGeAlD
Clodronate—SLC25A5—bone marrow—hematologic cancer	0.00452	0.0452	CbGeAlD
Clodronate—SLC25A6—testis—hematologic cancer	0.00445	0.0444	CbGeAlD
Clodronate—SLC25A5—lung—hematologic cancer	0.0041	0.0409	CbGeAlD
Clodronate—SLC25A5—testis—hematologic cancer	0.00387	0.0386	CbGeAlD
Clodronate—SLC25A4—lung—hematologic cancer	0.00384	0.0384	CbGeAlD
Clodronate—SLC25A4—testis—hematologic cancer	0.00362	0.0362	CbGeAlD
Clodronate—SLC25A6—lymph node—hematologic cancer	0.00322	0.0322	CbGeAlD
Clodronate—SLC25A5—lymph node—hematologic cancer	0.0028	0.028	CbGeAlD
Clodronate—SLC25A4—lymph node—hematologic cancer	0.00263	0.0262	CbGeAlD
Clodronate—PTGS2—hematopoietic system—hematologic cancer	0.00133	0.0133	CbGeAlD
Clodronate—PTGS2—blood—hematologic cancer	0.00088	0.00879	CbGeAlD
Clodronate—PTGS2—bone marrow—hematologic cancer	0.000852	0.00851	CbGeAlD
Clodronate—SLC25A5—Azacitidine—Pentostatin—hematologic cancer	0.000783	0.106	CbGdCrCtD
Clodronate—PTGS2—lung—hematologic cancer	0.000772	0.00771	CbGeAlD
Clodronate—SLC25A5—Azacitidine—Clofarabine—hematologic cancer	0.000698	0.0947	CbGdCrCtD
Clodronate—SLC25A6—Vinorelbine—Vinblastine—hematologic cancer	0.00069	0.0936	CbGdCrCtD
Clodronate—SLC25A6—Vinorelbine—Vincristine—hematologic cancer	0.00069	0.0936	CbGdCrCtD
Clodronate—SLC25A4—Vitamin A—Alitretinoin—hematologic cancer	0.000662	0.0898	CbGdCrCtD
Clodronate—SLC25A5—Azacitidine—Nelarabine—hematologic cancer	0.000656	0.089	CbGdCrCtD
Clodronate—PTGS2—lymph node—hematologic cancer	0.000528	0.00527	CbGeAlD
Clodronate—SLC25A5—Azacitidine—Fludarabine—hematologic cancer	0.000512	0.0695	CbGdCrCtD
Clodronate—SLC25A5—Azacitidine—Cytarabine—hematologic cancer	0.000484	0.0656	CbGdCrCtD
Clodronate—SLC25A5—Azacitidine—Gemcitabine—hematologic cancer	0.000484	0.0656	CbGdCrCtD
Clodronate—SLC25A5—Azacitidine—Cladribine—hematologic cancer	0.000471	0.064	CbGdCrCtD
Clodronate—SLC25A4—Tretinoin—Alitretinoin—hematologic cancer	0.000463	0.0628	CbGdCrCtD
Clodronate—SLC25A4—Isotretinoin—Alitretinoin—hematologic cancer	0.000463	0.0628	CbGdCrCtD
Clodronate—Dyspnoea—Gemcitabine—hematologic cancer	8.71e-05	0.000289	CcSEcCtD
Clodronate—Nausea—Vinblastine—hematologic cancer	8.69e-05	0.000288	CcSEcCtD
Clodronate—Abdominal pain upper—Epirubicin—hematologic cancer	8.69e-05	0.000288	CcSEcCtD
Clodronate—Anorexia—Cisplatin—hematologic cancer	8.68e-05	0.000288	CcSEcCtD
Clodronate—Gastrointestinal disorder—Irinotecan—hematologic cancer	8.66e-05	0.000287	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	8.64e-05	0.000286	CcSEcCtD
Clodronate—Vomiting—Lenalidomide—hematologic cancer	8.6e-05	0.000285	CcSEcCtD
Clodronate—Pruritus—Vinorelbine—hematologic cancer	8.6e-05	0.000285	CcSEcCtD
Clodronate—Rash—Lenalidomide—hematologic cancer	8.53e-05	0.000283	CcSEcCtD
Clodronate—Abdominal pain—Carmustine—hematologic cancer	8.53e-05	0.000283	CcSEcCtD
Clodronate—Dermatitis—Lenalidomide—hematologic cancer	8.52e-05	0.000283	CcSEcCtD
Clodronate—Diarrhoea—Bortezomib—hematologic cancer	8.52e-05	0.000282	CcSEcCtD
Clodronate—Decreased appetite—Gemcitabine—hematologic cancer	8.49e-05	0.000281	CcSEcCtD
Clodronate—Urticaria—Alitretinoin—hematologic cancer	8.49e-05	0.000281	CcSEcCtD
Clodronate—Vomiting—Hydroxyurea—hematologic cancer	8.48e-05	0.000281	CcSEcCtD
Clodronate—Angioedema—Triamcinolone—hematologic cancer	8.47e-05	0.000281	CcSEcCtD
Clodronate—Abdominal pain—Alitretinoin—hematologic cancer	8.45e-05	0.00028	CcSEcCtD
Clodronate—Gastrointestinal disorder—Gemcitabine—hematologic cancer	8.43e-05	0.00028	CcSEcCtD
Clodronate—Rash—Hydroxyurea—hematologic cancer	8.41e-05	0.000279	CcSEcCtD
Clodronate—Dermatitis—Hydroxyurea—hematologic cancer	8.41e-05	0.000279	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Epirubicin—hematologic cancer	8.39e-05	0.000278	CcSEcCtD
Clodronate—Urticaria—Ifosfamide—hematologic cancer	8.39e-05	0.000278	CcSEcCtD
Clodronate—Abdominal pain—Ifosfamide—hematologic cancer	8.35e-05	0.000277	CcSEcCtD
Clodronate—Diarrhoea—Vinorelbine—hematologic cancer	8.32e-05	0.000276	CcSEcCtD
Clodronate—Infection—Etoposide—hematologic cancer	8.29e-05	0.000275	CcSEcCtD
Clodronate—Connective tissue disorder—Prednisone—hematologic cancer	8.27e-05	0.000274	CcSEcCtD
Clodronate—Nausea—Melphalan—hematologic cancer	8.27e-05	0.000274	CcSEcCtD
Clodronate—Blood creatinine increased—Doxorubicin—hematologic cancer	8.25e-05	0.000273	CcSEcCtD
Clodronate—Dysphagia—Epirubicin—hematologic cancer	8.22e-05	0.000273	CcSEcCtD
Clodronate—Pruritus—Thiotepa—hematologic cancer	8.22e-05	0.000272	CcSEcCtD
Clodronate—Dehydration—Doxorubicin—hematologic cancer	8.19e-05	0.000271	CcSEcCtD
Clodronate—Abdominal pain—Vincristine—hematologic cancer	8.14e-05	0.00027	CcSEcCtD
Clodronate—Dyspnoea—Cisplatin—hematologic cancer	8.12e-05	0.000269	CcSEcCtD
Clodronate—Skin disorder—Etoposide—hematologic cancer	8.1e-05	0.000269	CcSEcCtD
Clodronate—Abdominal pain upper—Doxorubicin—hematologic cancer	8.04e-05	0.000266	CcSEcCtD
Clodronate—Nausea—Lenalidomide—hematologic cancer	8.04e-05	0.000266	CcSEcCtD
Clodronate—Urticaria—Mitoxantrone—hematologic cancer	7.97e-05	0.000264	CcSEcCtD
Clodronate—Anorexia—Etoposide—hematologic cancer	7.95e-05	0.000264	CcSEcCtD
Clodronate—Pruritus—Thalidomide—hematologic cancer	7.95e-05	0.000263	CcSEcCtD
Clodronate—Diarrhoea—Thiotepa—hematologic cancer	7.95e-05	0.000263	CcSEcCtD
Clodronate—Abdominal pain—Irinotecan—hematologic cancer	7.93e-05	0.000263	CcSEcCtD
Clodronate—Abdominal pain—Mitoxantrone—hematologic cancer	7.93e-05	0.000263	CcSEcCtD
Clodronate—Nausea—Hydroxyurea—hematologic cancer	7.93e-05	0.000263	CcSEcCtD
Clodronate—Vomiting—Bortezomib—hematologic cancer	7.92e-05	0.000262	CcSEcCtD
Clodronate—Decreased appetite—Cisplatin—hematologic cancer	7.91e-05	0.000262	CcSEcCtD
Clodronate—Pneumonia—Methotrexate—hematologic cancer	7.88e-05	0.000261	CcSEcCtD
Clodronate—Gastrointestinal disorder—Cisplatin—hematologic cancer	7.86e-05	0.000261	CcSEcCtD
Clodronate—Vomiting—Bleomycin—hematologic cancer	7.86e-05	0.00026	CcSEcCtD
Clodronate—Rash—Bortezomib—hematologic cancer	7.85e-05	0.00026	CcSEcCtD
Clodronate—Dermatitis—Bortezomib—hematologic cancer	7.84e-05	0.00026	CcSEcCtD
Clodronate—Rash—Bleomycin—hematologic cancer	7.79e-05	0.000258	CcSEcCtD
Clodronate—Dermatitis—Bleomycin—hematologic cancer	7.78e-05	0.000258	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Doxorubicin—hematologic cancer	7.76e-05	0.000257	CcSEcCtD
Clodronate—Vomiting—Vinorelbine—hematologic cancer	7.73e-05	0.000256	CcSEcCtD
Clodronate—Renal failure—Methotrexate—hematologic cancer	7.7e-05	0.000255	CcSEcCtD
Clodronate—Angioedema—Dexamethasone—hematologic cancer	7.69e-05	0.000255	CcSEcCtD
Clodronate—Angioedema—Betamethasone—hematologic cancer	7.69e-05	0.000255	CcSEcCtD
Clodronate—Diarrhoea—Thalidomide—hematologic cancer	7.68e-05	0.000255	CcSEcCtD
Clodronate—Rash—Vinorelbine—hematologic cancer	7.67e-05	0.000254	CcSEcCtD
Clodronate—Dermatitis—Vinorelbine—hematologic cancer	7.66e-05	0.000254	CcSEcCtD
Clodronate—Dysphagia—Doxorubicin—hematologic cancer	7.61e-05	0.000252	CcSEcCtD
Clodronate—Pruritus—Alitretinoin—hematologic cancer	7.56e-05	0.000251	CcSEcCtD
Clodronate—Infection—Triamcinolone—hematologic cancer	7.52e-05	0.000249	CcSEcCtD
Clodronate—Pruritus—Ifosfamide—hematologic cancer	7.47e-05	0.000248	CcSEcCtD
Clodronate—Dyspnoea—Etoposide—hematologic cancer	7.44e-05	0.000247	CcSEcCtD
Clodronate—Nausea—Bortezomib—hematologic cancer	7.4e-05	0.000245	CcSEcCtD
Clodronate—Vomiting—Thiotepa—hematologic cancer	7.38e-05	0.000245	CcSEcCtD
Clodronate—Diarrhoea—Carmustine—hematologic cancer	7.38e-05	0.000245	CcSEcCtD
Clodronate—Pneumonia—Epirubicin—hematologic cancer	7.37e-05	0.000244	CcSEcCtD
Clodronate—Nausea—Bleomycin—hematologic cancer	7.34e-05	0.000243	CcSEcCtD
Clodronate—Rash—Thiotepa—hematologic cancer	7.32e-05	0.000243	CcSEcCtD
Clodronate—Dermatitis—Thiotepa—hematologic cancer	7.31e-05	0.000242	CcSEcCtD
Clodronate—Diarrhoea—Alitretinoin—hematologic cancer	7.31e-05	0.000242	CcSEcCtD
Clodronate—Decreased appetite—Etoposide—hematologic cancer	7.25e-05	0.00024	CcSEcCtD
Clodronate—Diarrhoea—Ifosfamide—hematologic cancer	7.23e-05	0.00024	CcSEcCtD
Clodronate—Nausea—Vinorelbine—hematologic cancer	7.22e-05	0.000239	CcSEcCtD
Clodronate—Renal failure—Epirubicin—hematologic cancer	7.21e-05	0.000239	CcSEcCtD
Clodronate—Gastrointestinal disorder—Etoposide—hematologic cancer	7.2e-05	0.000239	CcSEcCtD
Clodronate—Vomiting—Thalidomide—hematologic cancer	7.14e-05	0.000237	CcSEcCtD
Clodronate—Rash—Thalidomide—hematologic cancer	7.08e-05	0.000235	CcSEcCtD
Clodronate—Dermatitis—Thalidomide—hematologic cancer	7.07e-05	0.000235	CcSEcCtD
Clodronate—Diarrhoea—Vincristine—hematologic cancer	7.05e-05	0.000234	CcSEcCtD
Clodronate—Pharyngitis—Methotrexate—hematologic cancer	6.98e-05	0.000231	CcSEcCtD
Clodronate—Urinary tract disorder—Methotrexate—hematologic cancer	6.94e-05	0.00023	CcSEcCtD
Clodronate—Pruritus—Gemcitabine—hematologic cancer	6.91e-05	0.000229	CcSEcCtD
Clodronate—Nausea—Thiotepa—hematologic cancer	6.9e-05	0.000229	CcSEcCtD
Clodronate—Urethral disorder—Methotrexate—hematologic cancer	6.89e-05	0.000229	CcSEcCtD
Clodronate—Diarrhoea—Mitoxantrone—hematologic cancer	6.86e-05	0.000227	CcSEcCtD
Clodronate—Diarrhoea—Irinotecan—hematologic cancer	6.86e-05	0.000227	CcSEcCtD
Clodronate—Vomiting—Carmustine—hematologic cancer	6.86e-05	0.000227	CcSEcCtD
Clodronate—Pneumonia—Doxorubicin—hematologic cancer	6.82e-05	0.000226	CcSEcCtD
Clodronate—Infection—Betamethasone—hematologic cancer	6.82e-05	0.000226	CcSEcCtD
Clodronate—Infection—Dexamethasone—hematologic cancer	6.82e-05	0.000226	CcSEcCtD
Clodronate—Rash—Carmustine—hematologic cancer	6.8e-05	0.000225	CcSEcCtD
Clodronate—Dermatitis—Carmustine—hematologic cancer	6.79e-05	0.000225	CcSEcCtD
Clodronate—Vomiting—Alitretinoin—hematologic cancer	6.79e-05	0.000225	CcSEcCtD
Clodronate—Anaemia—Prednisone—hematologic cancer	6.77e-05	0.000224	CcSEcCtD
Clodronate—Dyspnoea—Triamcinolone—hematologic cancer	6.75e-05	0.000224	CcSEcCtD
Clodronate—Rash—Alitretinoin—hematologic cancer	6.74e-05	0.000223	CcSEcCtD
Clodronate—Dermatitis—Alitretinoin—hematologic cancer	6.73e-05	0.000223	CcSEcCtD
Clodronate—Vomiting—Ifosfamide—hematologic cancer	6.71e-05	0.000223	CcSEcCtD
Clodronate—Angioedema—Prednisone—hematologic cancer	6.69e-05	0.000222	CcSEcCtD
Clodronate—Diarrhoea—Gemcitabine—hematologic cancer	6.68e-05	0.000222	CcSEcCtD
Clodronate—Nausea—Thalidomide—hematologic cancer	6.67e-05	0.000221	CcSEcCtD
Clodronate—Renal failure—Doxorubicin—hematologic cancer	6.67e-05	0.000221	CcSEcCtD
Clodronate—Dyspepsia—Triamcinolone—hematologic cancer	6.66e-05	0.000221	CcSEcCtD
Clodronate—Rash—Ifosfamide—hematologic cancer	6.66e-05	0.000221	CcSEcCtD
Clodronate—Dermatitis—Ifosfamide—hematologic cancer	6.65e-05	0.000221	CcSEcCtD
Clodronate—Urticaria—Etoposide—hematologic cancer	6.63e-05	0.00022	CcSEcCtD
Clodronate—Abdominal pain—Etoposide—hematologic cancer	6.59e-05	0.000219	CcSEcCtD
Clodronate—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	6.59e-05	0.00894	CbGdCrCtD
Clodronate—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	6.59e-05	0.00894	CbGdCrCtD
Clodronate—Vomiting—Vincristine—hematologic cancer	6.55e-05	0.000217	CcSEcCtD
Clodronate—Anorexia—Betamethasone—hematologic cancer	6.54e-05	0.000217	CcSEcCtD
Clodronate—Anorexia—Dexamethasone—hematologic cancer	6.54e-05	0.000217	CcSEcCtD
Clodronate—Urticaria—Prednisolone—hematologic cancer	6.54e-05	0.000217	CcSEcCtD
Clodronate—Pharyngitis—Epirubicin—hematologic cancer	6.53e-05	0.000217	CcSEcCtD
Clodronate—Urinary tract disorder—Epirubicin—hematologic cancer	6.5e-05	0.000215	CcSEcCtD
Clodronate—Rash—Vincristine—hematologic cancer	6.49e-05	0.000215	CcSEcCtD
Clodronate—Dermatitis—Vincristine—hematologic cancer	6.49e-05	0.000215	CcSEcCtD
Clodronate—Connective tissue disorder—Epirubicin—hematologic cancer	6.47e-05	0.000214	CcSEcCtD
Clodronate—Urethral disorder—Epirubicin—hematologic cancer	6.45e-05	0.000214	CcSEcCtD
Clodronate—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	6.44e-05	0.00874	CbGdCrCtD
Clodronate—Nausea—Carmustine—hematologic cancer	6.41e-05	0.000212	CcSEcCtD
Clodronate—Vomiting—Mitoxantrone—hematologic cancer	6.38e-05	0.000211	CcSEcCtD
Clodronate—Vomiting—Irinotecan—hematologic cancer	6.38e-05	0.000211	CcSEcCtD
Clodronate—Nausea—Alitretinoin—hematologic cancer	6.35e-05	0.00021	CcSEcCtD
Clodronate—Mediastinal disorder—Methotrexate—hematologic cancer	6.34e-05	0.00021	CcSEcCtD
Clodronate—Rash—Mitoxantrone—hematologic cancer	6.32e-05	0.00021	CcSEcCtD
Clodronate—Rash—Irinotecan—hematologic cancer	6.32e-05	0.00021	CcSEcCtD
Clodronate—Dermatitis—Mitoxantrone—hematologic cancer	6.32e-05	0.000209	CcSEcCtD
Clodronate—Dermatitis—Irinotecan—hematologic cancer	6.32e-05	0.000209	CcSEcCtD
Clodronate—Nausea—Ifosfamide—hematologic cancer	6.27e-05	0.000208	CcSEcCtD
Clodronate—Diarrhoea—Cisplatin—hematologic cancer	6.23e-05	0.000207	CcSEcCtD
Clodronate—Vomiting—Gemcitabine—hematologic cancer	6.21e-05	0.000206	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	6.19e-05	0.000205	CcSEcCtD
Clodronate—Rash—Gemcitabine—hematologic cancer	6.16e-05	0.000204	CcSEcCtD
Clodronate—Dermatitis—Gemcitabine—hematologic cancer	6.15e-05	0.000204	CcSEcCtD
Clodronate—Nausea—Vincristine—hematologic cancer	6.12e-05	0.000203	CcSEcCtD
Clodronate—Pharyngitis—Doxorubicin—hematologic cancer	6.04e-05	0.0002	CcSEcCtD
Clodronate—Dyspepsia—Betamethasone—hematologic cancer	6.04e-05	0.0002	CcSEcCtD
Clodronate—Dyspepsia—Dexamethasone—hematologic cancer	6.04e-05	0.0002	CcSEcCtD
Clodronate—Urinary tract disorder—Doxorubicin—hematologic cancer	6.01e-05	0.000199	CcSEcCtD
Clodronate—Urticaria—Triamcinolone—hematologic cancer	6.01e-05	0.000199	CcSEcCtD
Clodronate—Connective tissue disorder—Doxorubicin—hematologic cancer	5.98e-05	0.000198	CcSEcCtD
Clodronate—Urethral disorder—Doxorubicin—hematologic cancer	5.97e-05	0.000198	CcSEcCtD
Clodronate—Decreased appetite—Dexamethasone—hematologic cancer	5.97e-05	0.000198	CcSEcCtD
Clodronate—Decreased appetite—Betamethasone—hematologic cancer	5.97e-05	0.000198	CcSEcCtD
Clodronate—Nausea—Irinotecan—hematologic cancer	5.96e-05	0.000197	CcSEcCtD
Clodronate—Nausea—Mitoxantrone—hematologic cancer	5.96e-05	0.000197	CcSEcCtD
Clodronate—Infection—Prednisone—hematologic cancer	5.94e-05	0.000197	CcSEcCtD
Clodronate—Mediastinal disorder—Epirubicin—hematologic cancer	5.93e-05	0.000197	CcSEcCtD
Clodronate—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.93e-05	0.000196	CcSEcCtD
Clodronate—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.93e-05	0.000196	CcSEcCtD
Clodronate—Pruritus—Etoposide—hematologic cancer	5.9e-05	0.000196	CcSEcCtD
Clodronate—Skin disorder—Prednisone—hematologic cancer	5.81e-05	0.000192	CcSEcCtD
Clodronate—Nausea—Gemcitabine—hematologic cancer	5.8e-05	0.000192	CcSEcCtD
Clodronate—Vomiting—Cisplatin—hematologic cancer	5.79e-05	0.000192	CcSEcCtD
Clodronate—Rash—Cisplatin—hematologic cancer	5.74e-05	0.00019	CcSEcCtD
Clodronate—Dermatitis—Cisplatin—hematologic cancer	5.74e-05	0.00019	CcSEcCtD
Clodronate—Diarrhoea—Etoposide—hematologic cancer	5.71e-05	0.000189	CcSEcCtD
Clodronate—Anorexia—Prednisone—hematologic cancer	5.7e-05	0.000189	CcSEcCtD
Clodronate—Anaemia—Methotrexate—hematologic cancer	5.66e-05	0.000188	CcSEcCtD
Clodronate—Mediastinal disorder—Doxorubicin—hematologic cancer	5.49e-05	0.000182	CcSEcCtD
Clodronate—Urticaria—Betamethasone—hematologic cancer	5.45e-05	0.000181	CcSEcCtD
Clodronate—Urticaria—Dexamethasone—hematologic cancer	5.45e-05	0.000181	CcSEcCtD
Clodronate—Abdominal pain—Betamethasone—hematologic cancer	5.43e-05	0.00018	CcSEcCtD
Clodronate—Abdominal pain—Dexamethasone—hematologic cancer	5.43e-05	0.00018	CcSEcCtD
Clodronate—Nausea—Cisplatin—hematologic cancer	5.41e-05	0.000179	CcSEcCtD
Clodronate—Pruritus—Triamcinolone—hematologic cancer	5.35e-05	0.000177	CcSEcCtD
Clodronate—Vomiting—Etoposide—hematologic cancer	5.3e-05	0.000176	CcSEcCtD
Clodronate—Anaemia—Epirubicin—hematologic cancer	5.3e-05	0.000176	CcSEcCtD
Clodronate—Dyspepsia—Prednisone—hematologic cancer	5.26e-05	0.000174	CcSEcCtD
Clodronate—Rash—Etoposide—hematologic cancer	5.26e-05	0.000174	CcSEcCtD
Clodronate—Dermatitis—Etoposide—hematologic cancer	5.25e-05	0.000174	CcSEcCtD
Clodronate—Decreased appetite—Prednisone—hematologic cancer	5.2e-05	0.000172	CcSEcCtD
Clodronate—Rash—Prednisolone—hematologic cancer	5.19e-05	0.000172	CcSEcCtD
Clodronate—Dermatitis—Prednisolone—hematologic cancer	5.18e-05	0.000172	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.18e-05	0.000172	CcSEcCtD
Clodronate—Infection—Methotrexate—hematologic cancer	4.96e-05	0.000165	CcSEcCtD
Clodronate—Nausea—Etoposide—hematologic cancer	4.95e-05	0.000164	CcSEcCtD
Clodronate—Anaemia—Doxorubicin—hematologic cancer	4.9e-05	0.000162	CcSEcCtD
Clodronate—Nausea—Prednisolone—hematologic cancer	4.89e-05	0.000162	CcSEcCtD
Clodronate—Pruritus—Dexamethasone—hematologic cancer	4.86e-05	0.000161	CcSEcCtD
Clodronate—Pruritus—Betamethasone—hematologic cancer	4.86e-05	0.000161	CcSEcCtD
Clodronate—Skin disorder—Methotrexate—hematologic cancer	4.85e-05	0.000161	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.84e-05	0.000161	CcSEcCtD
Clodronate—Vomiting—Triamcinolone—hematologic cancer	4.81e-05	0.000159	CcSEcCtD
Clodronate—Rash—Triamcinolone—hematologic cancer	4.77e-05	0.000158	CcSEcCtD
Clodronate—Dermatitis—Triamcinolone—hematologic cancer	4.77e-05	0.000158	CcSEcCtD
Clodronate—Anorexia—Methotrexate—hematologic cancer	4.76e-05	0.000158	CcSEcCtD
Clodronate—Urticaria—Prednisone—hematologic cancer	4.75e-05	0.000157	CcSEcCtD
Clodronate—Abdominal pain—Prednisone—hematologic cancer	4.73e-05	0.000157	CcSEcCtD
Clodronate—Diarrhoea—Betamethasone—hematologic cancer	4.7e-05	0.000156	CcSEcCtD
Clodronate—Diarrhoea—Dexamethasone—hematologic cancer	4.7e-05	0.000156	CcSEcCtD
Clodronate—Infection—Epirubicin—hematologic cancer	4.65e-05	0.000154	CcSEcCtD
Clodronate—Skin disorder—Epirubicin—hematologic cancer	4.54e-05	0.000151	CcSEcCtD
Clodronate—Nausea—Triamcinolone—hematologic cancer	4.49e-05	0.000149	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.48e-05	0.000149	CcSEcCtD
Clodronate—Anorexia—Epirubicin—hematologic cancer	4.46e-05	0.000148	CcSEcCtD
Clodronate—Dyspnoea—Methotrexate—hematologic cancer	4.45e-05	0.000148	CcSEcCtD
Clodronate—Dyspepsia—Methotrexate—hematologic cancer	4.4e-05	0.000146	CcSEcCtD
Clodronate—Vomiting—Betamethasone—hematologic cancer	4.36e-05	0.000145	CcSEcCtD
Clodronate—Vomiting—Dexamethasone—hematologic cancer	4.36e-05	0.000145	CcSEcCtD
Clodronate—Decreased appetite—Methotrexate—hematologic cancer	4.34e-05	0.000144	CcSEcCtD
Clodronate—Rash—Dexamethasone—hematologic cancer	4.33e-05	0.000143	CcSEcCtD
Clodronate—Rash—Betamethasone—hematologic cancer	4.33e-05	0.000143	CcSEcCtD
Clodronate—Dermatitis—Dexamethasone—hematologic cancer	4.32e-05	0.000143	CcSEcCtD
Clodronate—Dermatitis—Betamethasone—hematologic cancer	4.32e-05	0.000143	CcSEcCtD
Clodronate—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.31e-05	0.000143	CcSEcCtD
Clodronate—Infection—Doxorubicin—hematologic cancer	4.3e-05	0.000142	CcSEcCtD
Clodronate—Pruritus—Prednisone—hematologic cancer	4.23e-05	0.00014	CcSEcCtD
Clodronate—Skin disorder—Doxorubicin—hematologic cancer	4.2e-05	0.000139	CcSEcCtD
Clodronate—Dyspnoea—Epirubicin—hematologic cancer	4.17e-05	0.000138	CcSEcCtD
Clodronate—Anorexia—Doxorubicin—hematologic cancer	4.12e-05	0.000137	CcSEcCtD
Clodronate—Dyspepsia—Epirubicin—hematologic cancer	4.12e-05	0.000136	CcSEcCtD
Clodronate—Diarrhoea—Prednisone—hematologic cancer	4.09e-05	0.000136	CcSEcCtD
Clodronate—Nausea—Betamethasone—hematologic cancer	4.08e-05	0.000135	CcSEcCtD
Clodronate—Nausea—Dexamethasone—hematologic cancer	4.08e-05	0.000135	CcSEcCtD
Clodronate—Decreased appetite—Epirubicin—hematologic cancer	4.06e-05	0.000135	CcSEcCtD
Clodronate—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.04e-05	0.000134	CcSEcCtD
Clodronate—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	3.98e-05	0.0054	CbGdCrCtD
Clodronate—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	3.98e-05	0.0054	CbGdCrCtD
Clodronate—Urticaria—Methotrexate—hematologic cancer	3.97e-05	0.000132	CcSEcCtD
Clodronate—Abdominal pain—Methotrexate—hematologic cancer	3.95e-05	0.000131	CcSEcCtD
Clodronate—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	3.89e-05	0.00527	CbGdCrCtD
Clodronate—Dyspnoea—Doxorubicin—hematologic cancer	3.86e-05	0.000128	CcSEcCtD
Clodronate—Dyspepsia—Doxorubicin—hematologic cancer	3.81e-05	0.000126	CcSEcCtD
Clodronate—Vomiting—Prednisone—hematologic cancer	3.8e-05	0.000126	CcSEcCtD
Clodronate—Rash—Prednisone—hematologic cancer	3.77e-05	0.000125	CcSEcCtD
Clodronate—Dermatitis—Prednisone—hematologic cancer	3.77e-05	0.000125	CcSEcCtD
Clodronate—Decreased appetite—Doxorubicin—hematologic cancer	3.76e-05	0.000125	CcSEcCtD
Clodronate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.74e-05	0.000124	CcSEcCtD
Clodronate—Urticaria—Epirubicin—hematologic cancer	3.71e-05	0.000123	CcSEcCtD
Clodronate—Abdominal pain—Epirubicin—hematologic cancer	3.7e-05	0.000123	CcSEcCtD
Clodronate—Nausea—Prednisone—hematologic cancer	3.55e-05	0.000118	CcSEcCtD
Clodronate—Pruritus—Methotrexate—hematologic cancer	3.53e-05	0.000117	CcSEcCtD
Clodronate—Urticaria—Doxorubicin—hematologic cancer	3.44e-05	0.000114	CcSEcCtD
Clodronate—Abdominal pain—Doxorubicin—hematologic cancer	3.42e-05	0.000113	CcSEcCtD
Clodronate—Diarrhoea—Methotrexate—hematologic cancer	3.42e-05	0.000113	CcSEcCtD
Clodronate—Pruritus—Epirubicin—hematologic cancer	3.31e-05	0.00011	CcSEcCtD
Clodronate—Diarrhoea—Epirubicin—hematologic cancer	3.2e-05	0.000106	CcSEcCtD
Clodronate—Vomiting—Methotrexate—hematologic cancer	3.18e-05	0.000105	CcSEcCtD
Clodronate—Rash—Methotrexate—hematologic cancer	3.15e-05	0.000104	CcSEcCtD
Clodronate—Dermatitis—Methotrexate—hematologic cancer	3.15e-05	0.000104	CcSEcCtD
Clodronate—Pruritus—Doxorubicin—hematologic cancer	3.06e-05	0.000101	CcSEcCtD
Clodronate—SLC25A6—Disease—PTEN—hematologic cancer	3.05e-05	0.000177	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTEN—hematologic cancer	3.05e-05	0.000177	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	3.05e-05	0.000177	CbGpPWpGaD
Clodronate—SLC25A4—Disease—FGF2—hematologic cancer	3.03e-05	0.000176	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MYC—hematologic cancer	3.02e-05	0.000176	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TGFB1—hematologic cancer	3.02e-05	0.000175	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CG—hematologic cancer	3.01e-05	0.000175	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC35B2—hematologic cancer	3.01e-05	0.000175	CbGpPWpGaD
Clodronate—PTGS2—Disease—HDAC10—hematologic cancer	3.01e-05	0.000175	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3R1—hematologic cancer	2.98e-05	0.000173	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	2.98e-05	0.000173	CbGpPWpGaD
Clodronate—Vomiting—Epirubicin—hematologic cancer	2.97e-05	9.85e-05	CcSEcCtD
Clodronate—Nausea—Methotrexate—hematologic cancer	2.97e-05	9.84e-05	CcSEcCtD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	2.97e-05	0.000172	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HDC—hematologic cancer	2.96e-05	0.000172	CbGpPWpGaD
Clodronate—Diarrhoea—Doxorubicin—hematologic cancer	2.96e-05	9.81e-05	CcSEcCtD
Clodronate—SLC25A6—Metabolism—PIK3CB—hematologic cancer	2.95e-05	0.000172	CbGpPWpGaD
Clodronate—Rash—Epirubicin—hematologic cancer	2.95e-05	9.77e-05	CcSEcCtD
Clodronate—Dermatitis—Epirubicin—hematologic cancer	2.95e-05	9.76e-05	CcSEcCtD
Clodronate—SLC25A6—Disease—EP300—hematologic cancer	2.91e-05	0.000169	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—EP300—hematologic cancer	2.91e-05	0.000169	CbGpPWpGaD
Clodronate—SLC25A4—Disease—JAK2—hematologic cancer	2.9e-05	0.000168	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	2.83e-05	0.000165	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MDM2—hematologic cancer	2.83e-05	0.000164	CbGpPWpGaD
Clodronate—SLC25A6—Disease—SRC—hematologic cancer	2.83e-05	0.000164	CbGpPWpGaD
Clodronate—SLC25A5—Disease—KRAS—hematologic cancer	2.79e-05	0.000162	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CREBBP—hematologic cancer	2.79e-05	0.000162	CbGpPWpGaD
Clodronate—Nausea—Epirubicin—hematologic cancer	2.78e-05	9.21e-05	CcSEcCtD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.76e-05	0.00016	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MTOR—hematologic cancer	2.75e-05	0.00016	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3CB—hematologic cancer	2.75e-05	0.00016	CbGpPWpGaD
Clodronate—Vomiting—Doxorubicin—hematologic cancer	2.75e-05	9.12e-05	CcSEcCtD
Clodronate—SLC25A4—Disease—CD4—hematologic cancer	2.75e-05	0.00016	CbGpPWpGaD
Clodronate—Rash—Doxorubicin—hematologic cancer	2.73e-05	9.04e-05	CcSEcCtD
Clodronate—SLC25A6—Disease—STAT3—hematologic cancer	2.73e-05	0.000158	CbGpPWpGaD
Clodronate—Dermatitis—Doxorubicin—hematologic cancer	2.73e-05	9.03e-05	CcSEcCtD
Clodronate—SLC25A6—Disease—NRAS—hematologic cancer	2.72e-05	0.000158	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CDA—hematologic cancer	2.71e-05	0.000157	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	2.69e-05	0.000156	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—HRAS—hematologic cancer	2.67e-05	0.000155	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MAPK3—hematologic cancer	2.66e-05	0.000155	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CD—hematologic cancer	2.65e-05	0.000154	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ALB—hematologic cancer	2.61e-05	0.000152	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PC—hematologic cancer	2.61e-05	0.000151	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MAPK3—hematologic cancer	2.6e-05	0.000151	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MYC—hematologic cancer	2.59e-05	0.00015	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CDKN1B—hematologic cancer	2.58e-05	0.00015	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TGFB1—hematologic cancer	2.58e-05	0.00015	CbGpPWpGaD
Clodronate—Nausea—Doxorubicin—hematologic cancer	2.57e-05	8.52e-05	CcSEcCtD
Clodronate—SLC25A5—Disease—PIK3CA—hematologic cancer	2.57e-05	0.000149	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	2.56e-05	0.000149	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTEN—hematologic cancer	2.55e-05	0.000148	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MYC—hematologic cancer	2.53e-05	0.000147	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TGFB1—hematologic cancer	2.53e-05	0.000147	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	2.52e-05	0.000146	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GBA—hematologic cancer	2.52e-05	0.000146	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC35B2—hematologic cancer	2.52e-05	0.000146	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3R1—hematologic cancer	2.5e-05	0.000145	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—hematologic cancer	2.46e-05	0.000143	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—EP300—hematologic cancer	2.43e-05	0.000141	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—hematologic cancer	2.41e-05	0.00014	CbGpPWpGaD
Clodronate—PTGS2—Disease—SNCA—hematologic cancer	2.4e-05	0.00014	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPLP1—hematologic cancer	2.4e-05	0.00014	CbGpPWpGaD
Clodronate—PTGS2—Disease—AGRN—hematologic cancer	2.4e-05	0.00014	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CDKN1A—hematologic cancer	2.39e-05	0.000139	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTEN—hematologic cancer	2.38e-05	0.000138	CbGpPWpGaD
Clodronate—SLC25A5—Disease—HRAS—hematologic cancer	2.37e-05	0.000138	CbGpPWpGaD
Clodronate—SLC25A6—Disease—KRAS—hematologic cancer	2.34e-05	0.000136	CbGpPWpGaD
Clodronate—PTGS2—Disease—LEF1—hematologic cancer	2.32e-05	0.000135	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CB—hematologic cancer	2.31e-05	0.000134	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTAP—hematologic cancer	2.3e-05	0.000134	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	2.3e-05	0.000134	CbGpPWpGaD
Clodronate—PTGS2—Disease—HMMR—hematologic cancer	2.28e-05	0.000132	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—hematologic cancer	2.27e-05	0.000132	CbGpPWpGaD
Clodronate—SLC25A4—Disease—EP300—hematologic cancer	2.27e-05	0.000132	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	2.26e-05	0.000131	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SRC—hematologic cancer	2.21e-05	0.000128	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	2.2e-05	0.000128	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	2.19e-05	0.000127	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PIK3CA—hematologic cancer	2.15e-05	0.000125	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PIK3CA—hematologic cancer	2.15e-05	0.000125	CbGpPWpGaD
Clodronate—PTGS2—Disease—ELL—hematologic cancer	2.14e-05	0.000124	CbGpPWpGaD
Clodronate—SLC25A4—Disease—STAT3—hematologic cancer	2.13e-05	0.000124	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TP53—hematologic cancer	2.13e-05	0.000123	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	2.12e-05	0.000123	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NRAS—hematologic cancer	2.12e-05	0.000123	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	2.12e-05	0.000123	CbGpPWpGaD
Clodronate—SLC25A5—Disease—AKT1—hematologic cancer	2.1e-05	0.000122	CbGpPWpGaD
Clodronate—PTGS2—Disease—ACP5—hematologic cancer	2.08e-05	0.000121	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	2.07e-05	0.00012	CbGpPWpGaD
Clodronate—PTGS2—Disease—NCOR2—hematologic cancer	2.06e-05	0.000119	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—FHL2—hematologic cancer	2.05e-05	0.000119	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MAPK3—hematologic cancer	2.03e-05	0.000118	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	2.02e-05	0.000117	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AGRN—hematologic cancer	2.01e-05	0.000117	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTEN—hematologic cancer	1.99e-05	0.000116	CbGpPWpGaD
Clodronate—SLC25A6—Disease—HRAS—hematologic cancer	1.99e-05	0.000116	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MYC—hematologic cancer	1.98e-05	0.000115	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TGFB1—hematologic cancer	1.97e-05	0.000115	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.97e-05	0.000114	CbGpPWpGaD
Clodronate—PTGS2—Disease—IDH1—hematologic cancer	1.96e-05	0.000114	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—hematologic cancer	1.95e-05	0.000113	CbGpPWpGaD
Clodronate—PTGS2—Disease—GSTO1—hematologic cancer	1.94e-05	0.000113	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.91e-05	0.000111	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—IDH2—hematologic cancer	1.91e-05	0.000111	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMMR—hematologic cancer	1.91e-05	0.000111	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—hematologic cancer	1.9e-05	0.000111	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—EP300—hematologic cancer	1.9e-05	0.00011	CbGpPWpGaD
Clodronate—PTGS2—Disease—AGO2—hematologic cancer	1.9e-05	0.00011	CbGpPWpGaD
Clodronate—PTGS2—Disease—HDAC9—hematologic cancer	1.88e-05	0.000109	CbGpPWpGaD
Clodronate—PTGS2—Disease—H3F3B—hematologic cancer	1.86e-05	0.000108	CbGpPWpGaD
Clodronate—SLC25A4—Disease—KRAS—hematologic cancer	1.83e-05	0.000106	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.81e-05	0.000105	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PIK3CA—hematologic cancer	1.8e-05	0.000105	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.8e-05	0.000105	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ARNTL—hematologic cancer	1.79e-05	0.000104	CbGpPWpGaD
Clodronate—PTGS2—Disease—NPM1—hematologic cancer	1.79e-05	0.000104	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.76e-05	0.000102	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AKT1—hematologic cancer	1.76e-05	0.000102	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.76e-05	0.000102	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—AKT1—hematologic cancer	1.76e-05	0.000102	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CA9—hematologic cancer	1.75e-05	0.000101	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ACP5—hematologic cancer	1.75e-05	0.000101	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NCOR2—hematologic cancer	1.72e-05	0.0001	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGF19—hematologic cancer	1.71e-05	9.95e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPS14—hematologic cancer	1.7e-05	9.87e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—DKK1—hematologic cancer	1.69e-05	9.79e-05	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3CA—hematologic cancer	1.68e-05	9.75e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—STAT5B—hematologic cancer	1.67e-05	9.72e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NUP98—hematologic cancer	1.67e-05	9.72e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—IDH1—hematologic cancer	1.64e-05	9.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.64e-05	9.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CST3—hematologic cancer	1.64e-05	9.5e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.63e-05	9.45e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—ADCY7—hematologic cancer	1.62e-05	9.43e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCC3—hematologic cancer	1.62e-05	9.43e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTO1—hematologic cancer	1.62e-05	9.43e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TXN—hematologic cancer	1.62e-05	9.43e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NUP214—hematologic cancer	1.61e-05	9.37e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SPHK1—hematologic cancer	1.59e-05	9.22e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—XIAP—hematologic cancer	1.58e-05	9.18e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTR—hematologic cancer	1.58e-05	9.18e-05	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HRAS—hematologic cancer	1.55e-05	9.02e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—ENO2—hematologic cancer	1.55e-05	9e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SMARCA4—hematologic cancer	1.54e-05	8.94e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—UGT1A1—hematologic cancer	1.53e-05	8.86e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.49e-05	8.68e-05	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—hematologic cancer	1.49e-05	8.64e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC22A1—hematologic cancer	1.48e-05	8.62e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CRABP1—hematologic cancer	1.48e-05	8.62e-05	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—AKT1—hematologic cancer	1.47e-05	8.55e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SDC1—hematologic cancer	1.47e-05	8.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALOX5—hematologic cancer	1.45e-05	8.4e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.45e-05	8.4e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—LCK—hematologic cancer	1.42e-05	8.26e-05	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CA—hematologic cancer	1.41e-05	8.17e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NUP98—hematologic cancer	1.4e-05	8.14e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—H3F3A—hematologic cancer	1.39e-05	8.1e-05	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AKT1—hematologic cancer	1.37e-05	7.97e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NCOA3—hematologic cancer	1.36e-05	7.9e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ADCY7—hematologic cancer	1.36e-05	7.9e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PRKCZ—hematologic cancer	1.36e-05	7.87e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NUP214—hematologic cancer	1.35e-05	7.84e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.34e-05	7.76e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CALR—hematologic cancer	1.33e-05	7.73e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCG2—hematologic cancer	1.32e-05	7.68e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTR—hematologic cancer	1.32e-05	7.68e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PARP1—hematologic cancer	1.31e-05	7.6e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ENO2—hematologic cancer	1.3e-05	7.54e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FBXW7—hematologic cancer	1.29e-05	7.48e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CXCR4—hematologic cancer	1.26e-05	7.34e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HDAC2—hematologic cancer	1.26e-05	7.34e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTT1—hematologic cancer	1.26e-05	7.31e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CD44—hematologic cancer	1.25e-05	7.25e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.24e-05	7.2e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CBL—hematologic cancer	1.23e-05	7.15e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SDC1—hematologic cancer	1.23e-05	7.14e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.22e-05	7.09e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.17e-05	6.82e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HSP90AA1—hematologic cancer	1.17e-05	6.82e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.16e-05	6.74e-05	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AKT1—hematologic cancer	1.15e-05	6.67e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—STAT1—hematologic cancer	1.13e-05	6.58e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.11e-05	6.44e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—GRB2—hematologic cancer	1.06e-05	6.15e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PDGFA—hematologic cancer	1.06e-05	6.14e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CD44—hematologic cancer	1.05e-05	6.07e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NQO1—hematologic cancer	1.05e-05	6.07e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—KITLG—hematologic cancer	1.04e-05	6.05e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.02e-05	5.95e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—STAT5A—hematologic cancer	1.02e-05	5.91e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDKN2B—hematologic cancer	1.01e-05	5.86e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYCS—hematologic cancer	9.89e-06	5.75e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HSP90AA1—hematologic cancer	9.83e-06	5.71e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CD86—hematologic cancer	9.76e-06	5.67e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HES1—hematologic cancer	9.63e-06	5.59e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NCOR1—hematologic cancer	9.57e-06	5.56e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGF1—hematologic cancer	9.46e-06	5.5e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FOXO1—hematologic cancer	9.33e-06	5.42e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PDGFRB—hematologic cancer	9.31e-06	5.41e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PDGFRA—hematologic cancer	9.16e-06	5.32e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PRKCG—hematologic cancer	9.13e-06	5.31e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—JAK1—hematologic cancer	9.13e-06	5.31e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.85e-06	5.14e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTP1—hematologic cancer	8.72e-06	5.07e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTHFR—hematologic cancer	8.46e-06	4.91e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.44e-06	4.9e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TERT—hematologic cancer	8.43e-06	4.9e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HLA-A—hematologic cancer	8.43e-06	4.9e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCB1—hematologic cancer	8.26e-06	4.8e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PDGFB—hematologic cancer	8.23e-06	4.78e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TSC2—hematologic cancer	8.05e-06	4.67e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTM1—hematologic cancer	8.01e-06	4.66e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NCOR1—hematologic cancer	8.01e-06	4.66e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGFR3—hematologic cancer	7.74e-06	4.5e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—BAD—hematologic cancer	7.34e-06	4.26e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOTCH1—hematologic cancer	7.27e-06	4.22e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CD80—hematologic cancer	7.12e-06	4.14e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—KIT—hematologic cancer	7.11e-06	4.13e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTHFR—hematologic cancer	7.08e-06	4.11e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PTPN11—hematologic cancer	6.98e-06	4.06e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CREB1—hematologic cancer	6.76e-06	3.93e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—BRAF—hematologic cancer	6.68e-06	3.88e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6R—hematologic cancer	6.6e-06	3.83e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CREBBP—hematologic cancer	6.59e-06	3.83e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MAP2K1—hematologic cancer	6.29e-06	3.65e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CD—hematologic cancer	6.25e-06	3.63e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.24e-06	3.63e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGF2—hematologic cancer	5.98e-06	3.47e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CG—hematologic cancer	5.95e-06	3.46e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3R1—hematologic cancer	5.9e-06	3.43e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—JAK2—hematologic cancer	5.73e-06	3.33e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MDM2—hematologic cancer	5.6e-06	3.25e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CREBBP—hematologic cancer	5.52e-06	3.21e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CB—hematologic cancer	5.45e-06	3.16e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTOR—hematologic cancer	5.45e-06	3.16e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CD4—hematologic cancer	5.43e-06	3.16e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CD—hematologic cancer	5.23e-06	3.04e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALB—hematologic cancer	5.16e-06	3e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDKN1B—hematologic cancer	5.11e-06	2.97e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3R1—hematologic cancer	4.94e-06	2.87e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDKN1A—hematologic cancer	4.72e-06	2.74e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PTEN—hematologic cancer	4.71e-06	2.73e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CB—hematologic cancer	4.56e-06	2.65e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—EP300—hematologic cancer	4.49e-06	2.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SRC—hematologic cancer	4.36e-06	2.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—STAT3—hematologic cancer	4.21e-06	2.44e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NRAS—hematologic cancer	4.2e-06	2.44e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MAPK3—hematologic cancer	4.02e-06	2.34e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PTEN—hematologic cancer	3.94e-06	2.29e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MYC—hematologic cancer	3.91e-06	2.27e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFB1—hematologic cancer	3.9e-06	2.27e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—EP300—hematologic cancer	3.76e-06	2.18e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—KRAS—hematologic cancer	3.61e-06	2.1e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CA—hematologic cancer	3.32e-06	1.93e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HRAS—hematologic cancer	3.07e-06	1.78e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—hematologic cancer	2.94e-06	1.71e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CA—hematologic cancer	2.78e-06	1.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT1—hematologic cancer	2.71e-06	1.58e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AKT1—hematologic cancer	2.27e-06	1.32e-05	CbGpPWpGaD
